Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma

Grant

Date/time Interval

  • September 30, 2015 - August 31, 2021
  • Total Award Amount

  • 1607815.00
  • Direct Costs

  • 1093750.00
  • Sponsor Award Id

  • R01NS095626
  • Contributor

  • Erik Roberson   Investigator  
  • George Gillespie   Investigator  
  • Louis Nabors M.D.   Investigator  
  • Qiang Ding   Investigator  
  • Xiaosi Han   Principal Investigator  
  • Xinyang Zhao Ph.D.   Investigator